Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease
- 1 February 2013
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 26 (2), 204-212
- https://doi.org/10.1038/modpathol.2012.165
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2009
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentBlood, 2009
- The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic featuresLeukemia, 2008
- Risk factors for leukemic transformation in patients with primary myelofibrosisCancer, 2008
- Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosisLeukemia Research, 2007
- Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL)Leukemia Research, 2007
- Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic Myeloproliferative DisordersThe Journal of Molecular Diagnostics, 2007
- Chronic Myelomonocytic Leukemia Evolving From Preexisting Myelodysplasia Shares Many Features With De Novo DiseaseAmerican Journal of Clinical Pathology, 2006
- Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistologyLaboratory Investigation, 2006
- Bone Marrow Histopathology in Myeloproliferative Disorders—Current Diagnostic ApproachSeminars in Hematology, 2005